EODData

FRA, 6A3A: Autolus Therapeutics plc

13 Nov 2025
LAST:

1.160

CHANGE:
 0.02
OPEN:
1.160
HIGH:
1.160
ASK:
0.000
VOLUME:
2.3K
CHG(%):
1.75
PREV:
1.140
LOW:
1.160
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Nov 251.1601.1601.1601.1602.3K
12 Nov 251.3201.3201.1401.1402.3K
11 Nov 251.1501.1501.1501.1501.0K
10 Nov 251.1501.1501.1501.1501.0K
07 Nov 251.1701.2001.1701.2001.0K
06 Nov 251.1801.1801.1801.180300
05 Nov 251.2101.2101.2101.210300
04 Nov 251.3101.3101.3101.310300
03 Nov 251.3301.3301.3301.330300
31 Oct 251.3001.3001.3001.300300

COMPANY PROFILE

Name:Autolus Therapeutics plc
About:Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1 and TRBC2; AUTO6NG, a programmed T cell investigational therapy targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate to treat multiple myeloma. It focuses on developing AUTO5, a preclinical TRBC2 programmed T cell product candidate for the treatment of peripheral T-cell lymphoma. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:The Mediaworks, London, United Kingdom, W12 7FP
Website:https://www.autolus.com
ISIN:US05280R1005
LEI:549300C0KZP8EYROLL02

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-1.52 
Forward P/E:-0.71 
PEG Ratio:0.08 
Price to Sales:11.73 
Price to Book:1.01 
Profit Margin:-0.13 
Operating Margin:-2.93 
Return on Assets:-0.21 
Return on Equity:-0.52 
Revenue:25.98M 
Shares:266.14M 
Market Cap:308.72M 

TECHNICAL INDICATORS

MA5:1.160.0%
MA10:1.214.6%
MA20:1.2910.9%
MA50:1.2810.6%
MA100:1.5835.8%
MA200:1.5735.4%
STO9:10.53 
STO14:7.41 
RSI14:38.89 
WPR14:-92.59 
MTM14:-0.16
ROC14:-0.12 
ATR:0.06 
Week High:1.3213.8%
Week Low:1.141.8%
Month High:1.4625.9%
Month Low:1.1435.4%
Year High:3.27182.0%
Year Low:1.0016.6%
Volatility:73.70